Latest News about MRNA
Recent news which mentions MRNA
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
September 15, 2023
From Benzinga
This 1 Number May Completely Change Your Opinion About Moderna
September 15, 2023
Tickers
MRNA
From Motley Fool
The 3 Most Undervalued Pharma Stocks to Buy in September 2023
September 14, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
September 14, 2023
From Benzinga
Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs
September 14, 2023
From Benzinga
Why COVID Vaccine Demand Might Not Be That Strong
September 14, 2023
From Motley Fool
The 7 Best Meme Stocks to Buy Now: September 2023
September 14, 2023
From InvestorPlace
Five things to know about the new COVID-19 vaccine
September 13, 2023
From MarketWatch
Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm
September 13, 2023
From InvestorPlace
Mainz Biomed Paves The Way For Early Colorectal Cancer Diagnosis And Even Prevention
September 13, 2023
From Benzinga
Europe Set To Launch Anti-Subsidy Probe Into Chinese EVs, American Airlines and Spirit Lower Profit Outlook, Manchester United's New Shirt Sponsor: Today's Top Stories
September 13, 2023
From Benzinga
Moderna, REV Group, Rocket Pharmaceuticals And Other Big Stocks Moving Higher On Wednesday
September 13, 2023
From Benzinga
Why Is Moderna Stock Trading Higher Today?
September 13, 2023
From Benzinga
Say Goodbye to Free COVID-19 Shots: CDC Approves Priced Boosters for Omicron Subvariants
September 13, 2023
From Benzinga
Moderna aims to prove it’s ‘more than a COVID company’
September 13, 2023
From MarketWatch
The 3 Most Undervalued Biotech Stocks to Buy in September 2023
September 12, 2023
From InvestorPlace
From MarketWatch
From Benzinga
Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits
September 11, 2023
From Benzinga
New Pfizer and Moderna COVID shots approved by FDA
September 11, 2023
From MarketWatch
Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market
September 11, 2023
From Benzinga
3 Meme Stocks That Could Actually Rebound in Q4
September 09, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
September 08, 2023
From Benzinga
COVID Vaccine Sales Are Declining. But Here's How They're Still Driving Growth at Moderna.
September 08, 2023
Tickers
MRNA
From Motley Fool
2 Nasdaq 100 Stocks That Are Surefire Buys in September and 1 to Avoid Like the Plague
September 08, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.